A clinical study to evaluate efficacy of Dalzbone capsules in fracture healing of long bone fracture of leg
Phase 2
Completed
- Conditions
- Health Condition 1: null- long bone fracture of leg
- Registration Number
- CTRI/2015/06/005850
- Lead Sponsor
- Pharmanza Herbal Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Radiologically diagnosed traumatic, simple as well as closed long bone fracture of Arms and leg.
-Fractures with internal fixation.
-Willing to give inform consent.
-0-5 days from the incident of fracture
Exclusion Criteria
-Pathological fracture.
-Fracture patients with diabetes.
-Pregnant and breast feeding women.
-Patients with end organ failure.
-History of allergy to herbal medicines.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fracture union confirmed by radiological assessmentTimepoint: at baseline after four week after six week and after eight week
- Secondary Outcome Measures
Name Time Method Restoration of functional motility confirmed by clinical assessmentTimepoint: at baseline after four week after six week and after eight week